Terms: = Prostate cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4 AND Prognosis
48 results:
1. EZH2-mediated development of therapeutic resistance in cancer.
Kaur P; Shankar E; Gupta S
Cancer Lett; 2024 Apr; 586():216706. PubMed ID: 38331087
[TBL] [Abstract] [Full Text] [Related]
2. CAV1 and KRT5 are potential targets for prostate cancer.
Guo L; Liu Y; Yang T; Wang G; Liu J; Li S; Liu B; Cai J
Medicine (Baltimore); 2023 Dec; 102(49):e36473. PubMed ID: 38065913
[TBL] [Abstract] [Full Text] [Related]
3. Targeting DNA methylation and B7-H3 in RB1-deficient and neuroendocrine prostate cancer.
Yamada Y; Venkadakrishnan VB; Mizuno K; Bakht M; Ku SY; Garcia MM; Beltran H
Sci Transl Med; 2023 Nov; 15(722):eadf6732. PubMed ID: 37967200
[TBL] [Abstract] [Full Text] [Related]
4. Identification of DNA damage response-related genes as biomarkers for castration-resistant prostate cancer.
Oshima M; Takayama KI; Yamada Y; Kimura N; Kume H; Fujimura T; Inoue S
Sci Rep; 2023 Nov; 13(1):19602. PubMed ID: 37950047
[TBL] [Abstract] [Full Text] [Related]
5. HIRA-mediated loading of histone variant H3.3 controls androgen-induced transcription by regulation of AR/BRD4 complex assembly at enhancers.
Morozov VM; Riva A; Sarwar S; Kim WJ; Li J; Zhou L; Licht JD; Daaka Y; Ishov AM
Nucleic Acids Res; 2023 Oct; 51(19):10194-10217. PubMed ID: 37638746
[TBL] [Abstract] [Full Text] [Related]
6. Influence of ADT on B7-H3 expression during CRPC progression from hormone-naïve prostate cancer.
Kang N; Xue H; Lin YY; Dong X; Classen A; Wu R; Jin Y; Lin D; Volik S; Ong C; Gleave M; Collins C; Wang Y
Cancer Gene Ther; 2023 Oct; 30(10):1382-1389. PubMed ID: 37452083
[TBL] [Abstract] [Full Text] [Related]
7. A first-in-class HBO1 inhibitor WM-3835 inhibits castration-resistant prostate cancer cell growth in vitro and in vivo.
Mi YY; Ji Y; Zhang L; Sun CY; Wei BB; Yang DJ; Wan HY; Qi XW; Wu S; Zhu LJ
Cell Death Dis; 2023 Jan; 14(1):67. PubMed ID: 36709328
[TBL] [Abstract] [Full Text] [Related]
8. Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer.
Liu P; Wang W; Wang F; Fan J; Guo J; Wu T; Lu D; Zhou Q; Liu Z; Wang Y; Shang Z; Chan FL; Yang W; Li X; Zhao SC; Zheng Q; Wang F; Wu D
J Transl Med; 2023 Jan; 21(1):40. PubMed ID: 36681849
[TBL] [Abstract] [Full Text] [Related]
9. Correlation of expression of Major Vault Protein with androgen receptor and immune checkpoint protein B7-H3, and with poor prognosis in prostate cancer.
Nunes-Xavier CE; Emaldi M; Guldvik IJ; Ramberg H; Taskén KA; Mælandsmo GM; Fodstad Ø; Llarena R; Pulido R; López JI
Pathol Res Pract; 2023 Jan; 241():154243. PubMed ID: 36481650
[TBL] [Abstract] [Full Text] [Related]
10. Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced prostate cancer: Differences in Genomic Landscape Based on Race.
Zimmerman R; Bilen MA; Heath EI; Nandagopal L; Swami U; Kessel A; Jaeger E; Wesolowski S; Hernanadez EJ; Chipman J; Mack A; Ravindranathan D; Maughan BL; Nussenzveig R; Yandell M; Kohli M; Lilly MB; Sartor AO; Agarwal N; Barata PC
Oncologist; 2022 Oct; 27(10):e815-e818. PubMed ID: 36036607
[TBL] [Abstract] [Full Text] [Related]
11. CD276 is an important player in macrophage recruitment into the tumor and an upstream regulator for PAI-1.
Durlanik S; Fundel-Clemens K; Viollet C; Huber HJ; Lenter M; Kitt K; Pflanz S
Sci Rep; 2021 Jul; 11(1):14849. PubMed ID: 34290311
[TBL] [Abstract] [Full Text] [Related]
12. Expression patterns of the immune checkpoint ligand CD276 in urothelial carcinoma.
Aicher WK; Korn M; Reitnauer L; Maurer FB; Hennenlotter J; Black PC; Todenhofer T; Bedke J; Stenzl A
BMC Urol; 2021 Apr; 21(1):60. PubMed ID: 33845814
[TBL] [Abstract] [Full Text] [Related]
13. B7-H3 Promotes prostate cancer Progression in Mice by Antagonizing Myeloid-Derived Suppressor Cell Apoptosis.
Zhou Y; Zhang G; Zhang W; Wei X; Hou J; Huang Y
Technol Cancer Res Treat; 2020; 19():1533033820971649. PubMed ID: 33280506
[TBL] [Abstract] [Full Text] [Related]
14. Epigenetic modification-dependent androgen receptor occupancy facilitates the ectopic TSPY1 expression in prostate cancer cells.
Leng X; Liu M; Tao D; Yang B; Zhang Y; He T; Xie S; Wang Z; Liu Y; Yang Y
Cancer Sci; 2021 Feb; 112(2):691-702. PubMed ID: 33185915
[TBL] [Abstract] [Full Text] [Related]
15. High B7-H3 expression is linked to increased risk of prostate cancer progression.
Bonk S; Tasdelen P; Kluth M; Hube-Magg C; Makrypidi-Fraune G; Möller K; Höflmayer D; Dwertmann Rico S; Büscheck F; Minner S; Heinzer H; Graefen M; Hinsch A; Luebke AM; Dum D; Uhlig R; Schlomm T; Sauter G; Simon R; Weidemann SA
Pathol Int; 2020 Oct; 70(10):733-742. PubMed ID: 32776718
[TBL] [Abstract] [Full Text] [Related]
16. Comprehensive Analysis of AR Alterations in Circulating Tumor DNA from Patients with Advanced prostate cancer.
Ledet EM; Lilly MB; Sonpavde G; Lin E; Nussenzveig RH; Barata PC; Yandell M; Nagy RJ; Kiedrowski L; Agarwal N; Sartor O
Oncologist; 2020 Apr; 25(4):327-333. PubMed ID: 32297439
[TBL] [Abstract] [Full Text] [Related]
17. B7-H4 is a potential prognostic biomarker of prostate cancer.
Li H; Piao L; Liu S; Cui Y; Xuan Y
Exp Mol Pathol; 2020 Jun; 114():104406. PubMed ID: 32088189
[TBL] [Abstract] [Full Text] [Related]
18. HNF1B-mediated repression of SLUG is suppressed by EZH2 in aggressive prostate cancer.
Wang J; He C; Gao P; Wang S; Lv R; Zhou H; Zhou Q; Zhang K; Sun J; Fan C; Ding G; Lan F
Oncogene; 2020 Feb; 39(6):1335-1346. PubMed ID: 31636385
[TBL] [Abstract] [Full Text] [Related]
19. EZH2 promotes gastric cancer cells proliferation by repressing p21 expression.
Xu J; Wang Z; Lu W; Jiang H; Lu J; Qiu J; Ye G
Pathol Res Pract; 2019 Jun; 215(6):152374. PubMed ID: 30952377
[TBL] [Abstract] [Full Text] [Related]
20. Epigenetic demethylation of sFRPs, with emphasis on sFRP4 activation, leading to Wnt signalling suppression and histone modifications in breast, prostate, and ovary cancer stem cells.
Deshmukh A; Arfuso F; Newsholme P; Dharmarajan A
Int J Biochem Cell Biol; 2019 Apr; 109():23-32. PubMed ID: 30710752
[TBL] [Abstract] [Full Text] [Related]
[Next]